Skip to main content
Screener/Healthcare/Biotechnology

XENE — Xenon Pharmaceuticals Inc.

NASDAQ
$39.60-17.75 (-30.95%)
Mid CapUnder $50HealthcareLow Beta
$35.97
$72.66
$39.50
$44.85
EPS (TTM)$-4.70
P/E Ratio-12.49
Dividend Yield—
Market Cap$5.44B
Volume15.60M
Prev Close$57.35
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q1 '26$0-$102.3M$-1.17——
Q4 '25$0-$105.3M$-1.31——
Q3 '25$0-$90.9M$-1.15——
Q2 '25$0-$84.7M$-1.07——
Q1 '25$7.5M-$65.0M$-0.83100.0%-867.3%
Q4 '24$0-$65.7M$-0.84——
Q3 '24$0-$62.8M$-0.81——
Q2 '24$0-$57.9M$-0.75——
Get Your Daily Market Recap